Currently, posts about Green Cross are surging on portal sites and stock market communities. Today, preliminary data shows that foreign investors made a net sale of 13,187 shares of Green Cross, while institutional investors made a net sale of 16,000 shares. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.
As of 1:31 p.m. on January 5, Green Cross shares were trading at 438,000 KRW, down 7.79% from the previous day. The trading volume stood at 445,710 shares, which is 54.06% of the five-day average trading volume.
In addition to Green Cross, investor posts are also rapidly increasing for ST Pharm (237690), LG Uplus (032640), and Daesung Eltec (025440).

※ Source: AI investment assistant AI Rasilo
※ This article was automatically generated in real time by a news algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
